Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

115.75
Delayed Data
As of 12:46pm ET
 -0.50 / -0.43%
Today’s Change
96.63
Today|||52-Week Range
177.93
+6.53%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close116.25
Today’s open117.09
Day’s range115.02 - 117.24
Volume105,052
Average volume (3 months)493,607
Market cap$2.9B
Dividend yield--
Data as of 12:46pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-75.10%
Earnings growth (this year)+1.83%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+796.87%
P/E ratioNM
Price/Sales107.40
Price/Book9.16

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...+0.29+0.52%
CLVSClovis Oncology Inc+1.28+1.91%
AKRXAkorn Inc+0.04+0.18%
GWPHGW Pharmaceuticals P...+3.13+2.62%
Data as of 1:01pm ET, 03/23/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$4.38
Annual revenue (last year)$25.0M
Annual profit (last year)-$412.8M
Net profit margin-1,654.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts


Search for Jobs